Kovacs L, Su Y
J Biomol Res Ther. 2021; 3(3).
PMID: 34414019
PMC: 8373195.
DOI: 10.4172/2167-7956.1000112.
Bondada V, Gal J, Mashburn C, Rodgers D, Larochelle K, Croall D
Biochim Biophys Acta Mol Cell Res. 2021; 1868(7):119019.
PMID: 33811937
PMC: 8588747.
DOI: 10.1016/j.bbamcr.2021.119019.
Hastings M, Gong K, Freibauer A, Courchesne C, Fan X, Sossin W
PLoS One. 2017; 12(10):e0186646.
PMID: 29053733
PMC: 5650170.
DOI: 10.1371/journal.pone.0186646.
Kovacs L, Su Y
Adv Exp Med Biol. 2017; 967:139-160.
PMID: 29047085
PMC: 7036267.
DOI: 10.1007/978-3-319-63245-2_9.
Montagne R, Berbon M, Doublet L, Debreuck N, Baranzelli A, Drobecq H
Cell Death Dis. 2015; 6:e1769.
PMID: 25996296
PMC: 4669710.
DOI: 10.1038/cddis.2015.132.
Calcium, calpain, and calcineurin in low-frequency depression of transmitter release.
Silverman-Gavrila L, Praver M, Mykles D, Charlton M
J Neurosci. 2013; 33(5):1975-90.
PMID: 23365236
PMC: 6619111.
DOI: 10.1523/JNEUROSCI.3092-12.2013.
Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer.
Storr S, Safuan S, Woolston C, Abdel-Fatah T, Deen S, Chan S
J Cell Mol Med. 2012; 16(10):2422-8.
PMID: 22435971
PMC: 3472029.
DOI: 10.1111/j.1582-4934.2012.01559.x.
Calpain chronicle--an enzyme family under multidisciplinary characterization.
Sorimachi H, Hata S, Ono Y
Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87(6):287-327.
PMID: 21670566
PMC: 3153876.
DOI: 10.2183/pjab.87.287.
The calpain system and cancer.
Storr S, Carragher N, Frame M, Parr T, Martin S
Nat Rev Cancer. 2011; 11(5):364-74.
PMID: 21508973
DOI: 10.1038/nrc3050.
Autolytic activation and localization in Schneider cells (S2) of calpain B from Drosophila.
Farkas A, Tompa P, Schad E, Sinka R, Jekely G, Friedrich P
Biochem J. 2003; 378(Pt 2):299-305.
PMID: 14614768
PMC: 1223968.
DOI: 10.1042/BJ20031310.
The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states.
Vanderklish P, Bahr B
Int J Exp Pathol. 2001; 81(5):323-39.
PMID: 11168679
PMC: 2517738.
DOI: 10.1111/j.1365-2613.2000.00169.x.
A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain.
Shields D, Schaecher K, Saido T, Banik N
Proc Natl Acad Sci U S A. 1999; 96(20):11486-91.
PMID: 10500203
PMC: 18060.
DOI: 10.1073/pnas.96.20.11486.
An immunocytochemical study of calpain II in the hippocampus of rats injected with kainate.
Ong W, Garey L, Tan K
Exp Brain Res. 1997; 113(1):117-29.
PMID: 9028780
DOI: 10.1007/BF02454147.
Autolysis parallels activation of mu-calpain.
Baki A, Tompa P, Alexa A, Molnar O, Friedrich P
Biochem J. 1996; 318 ( Pt 3):897-901.
PMID: 8836135
PMC: 1217702.
DOI: 10.1042/bj3180897.
Calpain processing of brain microtubules from the Atlantic cod, Gadus morhua.
Billger M, Nilsson E, Karlsson J, Wallin M
Mol Cell Biochem. 1993; 121(1):85-92.
PMID: 8510675
DOI: 10.1007/BF00928703.
Differential distribution of calpain in human lymphoid cells.
Deshpande R, Goust J, Banik N
Neurochem Res. 1993; 18(7):767-73.
PMID: 7690115
DOI: 10.1007/BF00966771.
A specific endogenous inhibitor of two forms of Ca++ activated neutral proteases in platelets.
Sakon M, Tsujinaka T, Kambayashi J, KOSAKI G
Experientia. 1982; 38(9):1099-101.
PMID: 6751859
DOI: 10.1007/BF01955389.
Cytosolic Ca2+-dependent neutral proteinases from rabbit liver: activation of the proenzymes by Ca2+ and substrate.
Pontremoli S, Melloni E, Salamino F, Sparatore B, Michetti M, HORECKER B
Proc Natl Acad Sci U S A. 1984; 81(1):53-6.
PMID: 6320172
PMC: 344608.
DOI: 10.1073/pnas.81.1.53.
Purification of a calcium-activated neutral proteinase from bovine brain.
Banik N, Hogan E, Jenkins M, McDonald J, McAlhaney W, Sostek M
Neurochem Res. 1983; 8(11):1389-405.
PMID: 6318144
DOI: 10.1007/BF00964996.
Qualitative analysis of skeletal myosin as substrate of Ca2+-activated neutral protease: comparison of filamentous and soluble, native, and L2-deficient myosin.
Pemrick S, Grebenau R
J Cell Biol. 1984; 99(6):2297-308.
PMID: 6094594
PMC: 2113535.
DOI: 10.1083/jcb.99.6.2297.